Streetbeat News

Price Targets

HCA

HCA Healthcare (NYSE:HCA) has received various analyst ratings over the last quarter, with 4 bullish, 6 somewhat bullish, and 2 indifferent ratings. The average 12-month price target among 12 analysts is $284.17, with a high of $315.00 and a low of $254.00. This target has decreased by 8.5% from the previous average of $310.56. Analysts provide these ratings based on research and forecasts, which are subject to change.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 6:00 pm

NTLA

Intellia Therapeutics (NASDAQ:NTLA) received 4 analyst ratings in the last quarter, with 1 bullish and 3 somewhat bullish, and no indifferent, somewhat bearish, or bearish ratings. The average price target is $80.75, which is significantly higher than the current price of $23.64, suggesting a substantial upside. However, this target represents a 31.28% decrease from the previous target of $117.50.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 6:00 pm

USFD

US Foods Hldg (NYSE:USFD) has received 4 analyst ratings in the last quarter, with 2 bullish and 2 somewhat bullish, and no indifferent, somewhat bearish, or bearish ratings. The average price target is $50.5, representing an upside from the current price of $41.8. This target has decreased by 2.26% from the previous target of $51.67. Analysts rate stocks based on future earnings potential and company risk profile, typically updating their ratings quarterly or after significant company events.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 6:00 pm

RPAY

Over the past 3 months, 6 Wall Street analysts have provided ratings for Repay Holdings (NASDAQ:RPAY), with 3 bullish, 1 somewhat bullish, and 2 indifferent. The average 12-month price target is $11.00, with a high of $15.00 and a low of $8.00. This target has decreased by 2.22% from the previous average of $11.25. Analysts rate stocks based on company financials, meetings, and insider communications, typically quarterly or after major updates.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 6:00 pm

PEPEUSD

SOLUSD

Analyst Bluntz predicts a 'rage pump' for altcoins, particularly Pepe Coin (PEPE) with a potential 30% increase, and Solana (SOL) after FTX's sell-offs. BlackRock's Ethereum ETF plan and a shopping spree in Ethereum-based altcoins indicate growing digital asset optimism. These topics will be discussed at Benzinga's Future of Digital Assets conference.

Portfolio Pulse from Murtuza Merchant

November 10, 2023 | 5:41 pm

APP

Applovin's stock price has increased following an upgrade in price target from $50 to $57 by Goldman Sachs.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 5:39 pm